New test aims to save mothers from preventable Birth-Related bleeding
NCT ID NCT06255002
Summary
This study is testing a new, faster bedside blood test (qLabs®FIB) to see if it works as well as the standard lab test for measuring a key blood-clotting protein (fibrinogen) in mothers experiencing severe bleeding after delivery. The goal is to help doctors get critical results faster right in the delivery room, which could lead to quicker treatment decisions. The study will enroll about 70 participants and will not change their standard medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Cochin Maternité Port Royal
RECRUITINGParis, 75014, France
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hôpital Necker-Enfants Malades
RECRUITINGParis, 75015, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.